About Alex Mayweg
Alex Mayweg has been a partner with Versant Ventures and head of the discovery engine Ridgeline since 2016. Alex is also a member of the selection committee of BaseLaunch. He worked in drug discovery at Roche for almost 14 years, taking leading roles in research and heading global medicinal chemistry. Alex has a Ph.D. in organic chemistry. He studied at Imperial College London, gained a PhD at Oxford University and went to Stanford University for his post-doctorate training.